|
1. Are you aware of the risk management programs that require physicians
to use stickers before a pharmacist can dispense a medication?
2. Have you received a prescription, as a written document, a verbal
order or as a FAX, for a medication that required a special sticker on
the prescription in order for you to dispense the medication?
3. About how often have you received a prescription for a medication
that required a special sticker but the sticker was missing?
| Almost always |
5% |
| Frequently |
5% |
| Never |
44% |
| Sometimes |
17% |
5. What procedure did you follow when the sticker was missing?
| did not dispense the drug |
14% |
| dispensed the drug after calling the drug company for further program information |
1% |
| dispensed the drug after calling the prescriber |
6% |
| dispensed the drug after verifying with the patient that the appropriate criteria have been met |
3% |
| dispensed the drug with no further inquiry |
1% |
| other |
12% |
Please indicate if you have received educational materials about the
Risk Management Program for any of the following medications
| ACCUTANE |
100% |
| ACTIQ |
15% |
| CLOZARIL |
70% |
| LOTRONEX |
25% |
| MIFEPREX |
4% |
| THALOMID |
54% |
| TIKOSYN |
36% |
| TRACLEER |
9% |
| TROVAN |
10% |
| XYREM |
4% |
| Others |
1% |
For the previous list of medications, how were you notified of the prescribing
restrictions?
| Letters from the product manufacturer |
92% |
| Manufacturer sponsored training programs |
16% |
| Continuing education |
29% |
| Public notices |
24% |
| Patient package inserts other product specific materials |
53% |
| Colleagues at work |
42% |
| I received no formal notification of the prescribing
restrictions |
9% |
| other |
7% |
|
